-
PBE Dashboard
- Holdings
Invesco Biotechnology & Genome ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Private Prime Fund | 30.72 mm | 30.72 mm shares | 11.95 | Short-term investment vehicle | Long | USA |
ILMN Illumina, Inc. | 14.88 mm | 103.21 k shares | 5.79 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 14.47 mm | 38.69 k shares | 5.63 | Common equity | Long | USA |
AMGN Amgen Inc. | 13.23 mm | 41.32 k shares | 5.15 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 12.85 mm | 48.21 k shares | 5.00 | Common equity | Long | USA |
Invesco Private Government Fund | 11.78 mm | 11.78 mm shares | 4.58 | Short-term investment vehicle | Long | USA |
BIIB Biogen Inc. | 11.56 mm | 66.46 k shares | 4.50 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 10.65 mm | 88.56 k shares | 4.14 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 9.84 mm | 149.35 k shares | 3.83 | Common equity | Long | USA |
MNKD MannKind Corporation | 9.68 mm | 1.37 mm shares | 3.77 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 9.51 mm | 286.41 k shares | 3.70 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 9.42 mm | 11.24 k shares | 3.66 | Common equity | Long | USA |
XNCR Xencor, Inc. | 9.03 mm | 429.95 k shares | 3.51 | Common equity | Long | USA |
INCY Incyte Corporation | 8.32 mm | 112.29 k shares | 3.24 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 7.99 mm | 174.38 k shares | 3.11 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 7.99 mm | 318.88 k shares | 3.11 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 7.85 mm | 360.01 k shares | 3.05 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 7.77 mm | 230.29 k shares | 3.02 | Common equity | Long | USA |
TECH Bio-Techne Corporation | 7.65 mm | 103.75 k shares | 2.98 | Common equity | Long | USA |
NTRA Natera, Inc. | 7.41 mm | 61.27 k shares | 2.88 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 7.17 mm | 895.43 k shares | 2.79 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 6.92 mm | 79.12 k shares | 2.69 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 6.83 mm | 467.90 k shares | 2.66 | Common equity | Long | USA |
RGEN Repligen Corporation | 6.78 mm | 50.46 k shares | 2.64 | Common equity | Long | USA |
OPK OPKO Health, Inc. | 6.74 mm | 4.47 mm shares | 2.62 | Common equity | Long | USA |
QGEN Qiagen N.V. | 6.74 mm | 160.13 k shares | 2.62 | Common equity | Long | Netherlands |
COLL Collegium Pharmaceutical, Inc. | 6.66 mm | 195.01 k shares | 2.59 | Common equity | Long | USA |
NVAX Novavax, Inc. | 6.35 mm | 660.93 k shares | 2.47 | Common equity | Long | USA |
VCEL Vericel Corporation | 6.06 mm | 137.59 k shares | 2.36 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 5.90 mm | 116.61 k shares | 2.29 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 5.88 mm | 267.98 k shares | 2.29 | Common equity | Long | USA |
CDNA CareDx, Inc | 5.13 mm | 231.74 k shares | 1.99 | Common equity | Long | USA |
Invesco Government & Agency Portfolio, Institutional Class | 95.54 k | 95.54 k shares | 0.04 | Short-term investment vehicle | Long | USA |